A new PNAS paper reports cannabidiol can help reduce epileptic seizures and improve social behaviors in children with Dravet syndrome.
The effect cannabidiol has on Lennox-Gastaut syndrome may be explained by the drug-drug interaction between CBD and anti-seizure medication.
Cannabis reduces the severity of symptoms by more than half in the short-term for people suffering from PTSD. Using cannabis reduces recurring thoughts of a traumatic event by 62%, flashbacks by 51%, irritability by 67%, and anxiety by 57% for those with PTSD. However, the reduction of symptoms is not permanent.
People with the specific genotype of the Cannabinoid receptor 1 gene may be more prone to cannabis use disorder. Researchers report those with FAAH rs324420 A continue to want more marijuana following use and are more drawn to cannabis-related imagery while under the influence of the drug.
Study provides further evidence the endocannabinoid system plays a crucial role in obsessive-compulsive disorder (OCD). Using cannabinoid drugs have a positive impact in helping control behaviors associated with OCD.
Dogs with epilepsy who received cannabidiol as part of a clinical trial had a reduction in the frequency of seizures.
People who used while dried cannabis flowers or cannabis with higher levels of THC had the greatest analgesic response to pain. Those who used CBD reported lower levels of pain relief.
Introducing and prescribing standard units for cannabis, which make people aware of the concentrations of THC in the product, could help improve mental health treatments and outcomes.
Many cannabis users don't know how much THC or CBD is considered an effective dose.
Researchers provide further evidence that the cannabis compound, CBD, is effective at reducing seizures in people with epilepsy. The new study reveals CBD significantly reduced seizures in people with Lennox-Gastaut syndrome. Previously, the researchers demonstrated CBD was effective at seizure control in Dravet syndrome.